Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on You might know this as Long COVID. - By Dr. Ashwini Avashiti.
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), refers to a range of symptoms that persist for weeks or months after the acute phase of a COVID-19 infection has resolved. Dr. Ashwini Avashiti explains that individuals with Long COVID may experience a variety of lingering symptoms, including fatigue, shortness of breath, cognitive difficulties often termed "brain fog," chest pain, and joint or muscle pain. These symptoms can fluctuate in intensity and may impact multiple organ systems, significantly affecting the quality of life.
Dr. Avashiti notes that while the exact mechanisms behind Long COVID are not fully understood, potential causes include ongoing inflammatory responses, immune system dysregulation, and residual viral particles. The condition can affect anyone who has had COVID-19, regardless of the severity of their initial illness. Diagnosis is primarily based on patient history and symptom presentation, as there are no specific tests for Long COVID.
Management of Long COVID often involves a multidisciplinary approach, including physical therapy, cognitive rehabilitation, and symptom-specific treatments. Dr. Avashiti emphasizes the importance of personalized care and ongoing research to better understand and treat this complex condition, as well as support for patients through dedicated Long COVID clinics and support groups.
Therefore, get an overall knowledg
See More Webinars @ Hidoc Webinars
1.
PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.
2.
Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.
3.
Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.
4.
AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer
5.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
1.
The Precision Revolution: Bispecific Antibodies and Antibody-Drug Conjugates Reshaping the Oncology Landscape
2.
Is AI The New Radiologist For Breast MRI?
3.
Uncovering New Hope for Follicular Lymphoma Patients
4.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
5.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation